Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
German generics drugmaker STADA Arzneimittel and Sweden’s Xbrane Biopharma are working together on a supply agreement for Ximluci (ranibizumab). 27 April 2023
The need to guarantee a new regulatory category for ‘value-added medicines’ has been proposed by the Asociación Española de Medicamentos Genéricos (AESEG), the 27 February 2023
Similis Bio, the JSR Life Sciences business unit focused on biosimilar development, has announced plans to enter into a partnership with Novel351k. 16 February 2023
Róbert Wessman, founder and chairman of Icelandic biosimilars company Alvotech and investment fund Aztiq, offers his vision for affordable global healthcare in 7 February 2023
Advanz Pharma has announced that it has entered into an exclusive agreement with Alvotech, a global biotech company specialising in the development and manufact 6 February 2023